共 50 条
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
被引:3
|作者:
Golubeva, Julia A.
[1
]
Sheptulina, Anna F.
[1
,2
]
Elkina, Anastasia Yu.
[1
,3
]
Liusina, Ekaterina O.
[1
]
Kiselev, Anton R.
[4
]
Drapkina, Oxana M.
[1
,2
]
机构:
[1] Natl Med Res Ctr Therapy & Prevent Med, Dept Fundamental & Appl Aspects Obes, Moscow 101990, Russia
[2] AI Evdokimov Moscow State Univ Med & Dent, Dept Therapy & Prevent Med, Moscow 127473, Russia
[3] Saratov State Med Univ, Dept Intermediate Level Therapy, Saratov 410012, Russia
[4] Natl Med Res Ctr Therapy & Prevent Med, Coordinating Ctr Fundamental Res, Moscow 101990, Russia
基金:
俄罗斯科学基金会;
关键词:
non-alcoholic fatty liver disease;
hypertension;
steatohepatitis;
BLOOD-PRESSURE;
INSULIN-RESISTANCE;
INCIDENT HYPERTENSION;
METABOLIC SYNDROME;
RISK-FACTORS;
CARDIOVASCULAR-DISEASE;
ADIPOSE-TISSUE;
FETUIN-A;
ASSOCIATION;
STEATOHEPATITIS;
D O I:
10.3390/biomedicines11092465
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.
引用
收藏
页数:25
相关论文